Clinical Trial: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access
Official Title: Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412
Brief Summary: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Detailed Summary: This treatment protocol will serve as a mechanism to continue to provide ficlatuzumab to patient 0001-000412, who was previously enrolled under protocol P05538 and whom the investigator believes is deriving clinical benefit from ficlatuzumab treatment.
Sponsor: AVEO Pharmaceuticals, Inc.
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: AVEO Pharmaceuticals, Inc.
Dates:
Date Received: March 14, 2014
Date Started:
Date Completion:
Last Updated: July 27, 2015
Last Verified: July 2015